Global Pharma Healthcare is voluntarily recalling all lots within expiry of their Artificial Tears Lubricant Eye Drops, distributed by /EzriCare, LLC- and Delsam Pharma, to the consumer level, due to possible contamination.

Tubing occlusion or a false “No Disposable Attached” alarm may cause the CADD system to delay, interrupt, or under-deliver therapy.

The Institute for Healthcare Improvement partnered with the American Board of Internal Medicine Foundation to identify key organizational-level drivers and change ideas that repair, build, and strengthen trust between health care organizations and clinicians, and between health care organizations and the communities they serve. This report describes a theory of how to repair, build, and strengthen trust, presented as a three-step approach with specific change ideas and associated measures for improvement.

IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution to the consumer level. This voluntary recall has been initiated because these lots may be subpotent. The company’s analyses show a slight decrease below 95.0% of its labeled amount in levothyroxin

Certain Philips masks can cause potential injury or death if magnets interfere with certain implanted metallic medical devices or metallic objects in the body.

Edgewell Personal Care Company (NYSE: EPC) today expanded its voluntary nationwide recall of three batches of Banana Boat Hair & Scalp Sunscreen Spray SPF 30 to the consumer level as outlined in the table below. One additional batch has been added to the original recall announced on July 29, 2022. A

A catheter hub defect may cause the Mahurkar Acute Dual Lumen High Flow Catheter to leak across the catheter’s two tubes.

The LifeSPARC System is being recalled because users can inadvertently cause extended pump stop. A software update will address this issue.

The LifeSPARC System is being recalled for risk that users can inadvertently cause extended pump stop when replacing the controller after software malfunction.

The LifeSPARC System is being recalled because users can inadvertently cause extended pump stop. A software update will address this issue.

This article provides numerous resources for creating a caregiving plan, including information and a link to IHI's The Conversation Project.

This article discusses the practice of physicians charging fees for medical correspondence with patients. IHI's President and CEO Kedar Mate is quoted encouraging patient-clinician interactions and discussing how charging for medical messaging could exacerbate inequities.

This is article is a Q&A with IHI Vice President Pedro Delgado discussing current workforce challenges for the health care sector, IHI's Joy in Work framework, and health equity.

RSDL Kits may leak, reducing the effectiveness of the kit when it is needed or exposing users unnecessarily to the decontamination lotion.

2023 Medical Device Recalls

Blood may enter the Cardiosave IABP through a damaged balloon catheter, causing pump shut-down, or patient exposure to helium or cross-contaminated blood

This article presents high-leverage, specific actions to improve equity in health care that are both possible and feasible for all health care organizations to undertake now.

The primary aim of the IHI innovation project described in this report was to assess the use of predictive analytics, specifically machine learning, to improve patient safety through emerging and existing approaches to predict risk, such as technologies and decision support tools. Specific attention was given to how predictive analytics and machine learning can assist in monitoring patient deterioration in the home setting for adults ages 18 and older.

Medical education and patient care are inextricably linked. At this time, with the limitations of simulation training and our continued dependence on educated physicians for clinical decision-making, one domain cannot exist without the other. The involvement of medical trainees in patient care means it is vital that the impact of changes to medical training programmes on patient outcomes are assessed with well-designed studies. The study, "National improvements in resident physician-reported patient safety after limiting first-year resident physicians’ extended duration work shifts,"1 by Weaver and colleagues published in this month’s issue of BMJ Quality and Safety signals the need for a robust discussion of education policy research within the field of medicine.

Before specifically addressing the approach used by Weaver et al,1 a review of the complexities involved in studying the impact of medical education policy is warranted.2 The field of ‘education outcomes research’...

Low-value care refers to tests or treatments for which there is little evidence of benefit or more harm than benefit, which can result in poor patient outcomes such as unwarranted secondary tests or adverse events. In this context, inefficient use of scarce healthcare resources threatens the sustainability of healthcare systems and low-value care is an obvious target. About 25%–30% of all care has been estimated to be of low value in countries such as Australia, Canada, Spain, Brazil and the USA, and this estimate rises to 80% for certain procedures.1 There is increasing interest to identify areas of low-value care based on available evidence, guidelines and expert opinion,2 including initiatives such as Choosing Wisely3 and the British Medical Journal’s Too Much Medicine campaign.4 These campaigns aim to reduce or stop low-value services (i.e., de-implement) from the ‘bottom up’, at micro or...